A new tractable method for generating Human Alveolar Macrophage Like cells in vitro to study lung inflammatory processes and diseases
ABSTRACT Alveolar macrophages (AMs) are unique lung resident cells that contact airborne pathogens and environmental particulates. The contribution of human AMs (HAM) to pulmonary diseases remains poorly understood due to difficulty in accessing them from human donors and their rapid phenotypic change duringin vitroculture. Thus, there remains an unmet need for cost-effective methods for generating and/or differentiating primary cells into a HAM phenotype, particularly important for translational and clinical studies. We developed cell culture conditions that mimic the lung alveolar environment in humans using lung lipids,i.e., Infasurf (calfactant, natural bovine surfactant) and lung-associated cytokines (GM-CSF, TGF-β, and IL-10) that facilitate the conversion of blood-obtained monocytes to an AM-Like (AML) phenotype and function in tissue culture. Similar to HAM, AML cells are particularly susceptible to bothMycobacterium tuberculosisand severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. This study reveals the importance of alveolar space components in the development and maintenance of HAM phenotype and function, and provides a readily accessible model to study HAM in infectious and inflammatory disease processes, as well as therapies and vaccines.<jats:sec id="s1a">IMPORTANCE Millions die annually from respiratory disorders. Lower respiratory track gas-exchanging alveoli maintain a precarious balance between fighting invaders and minimizing tissue damage. Key players herein are resident AMs. However, there are no easily accessiblein vitromodels of HAMs, presenting a huge scientific challenge. Here we present a novel model for generating AML cells based on differentiating blood monocytes in a defined lung component cocktail. This model is non-invasive, significantly less costly than performing a bronchoalveolar lavage, yields more AML cells than HAMs per donor and retains their phenotype in culture. We have applied this model to early studies ofM. tuberculosisand SARS-CoV-2. This model will significantly advance respiratory biology research..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
bioRxiv.org - (2024) vom: 23. Apr. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pahari, Susanta [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| doi: |
10.1101/2023.04.05.535806 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI039200795 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI039200795 | ||
| 003 | DE-627 | ||
| 005 | 20240425104824.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230409s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2023.04.05.535806 |2 doi | |
| 035 | |a (DE-627)XBI039200795 | ||
| 035 | |a (biorXiv)10.1101/2023.04.05.535806 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pahari, Susanta |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a A new tractable method for generating Human Alveolar Macrophage Like cells in vitro to study lung inflammatory processes and diseases |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a ABSTRACT Alveolar macrophages (AMs) are unique lung resident cells that contact airborne pathogens and environmental particulates. The contribution of human AMs (HAM) to pulmonary diseases remains poorly understood due to difficulty in accessing them from human donors and their rapid phenotypic change duringin vitroculture. Thus, there remains an unmet need for cost-effective methods for generating and/or differentiating primary cells into a HAM phenotype, particularly important for translational and clinical studies. We developed cell culture conditions that mimic the lung alveolar environment in humans using lung lipids,i.e., Infasurf (calfactant, natural bovine surfactant) and lung-associated cytokines (GM-CSF, TGF-β, and IL-10) that facilitate the conversion of blood-obtained monocytes to an AM-Like (AML) phenotype and function in tissue culture. Similar to HAM, AML cells are particularly susceptible to bothMycobacterium tuberculosisand severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. This study reveals the importance of alveolar space components in the development and maintenance of HAM phenotype and function, and provides a readily accessible model to study HAM in infectious and inflammatory disease processes, as well as therapies and vaccines.<jats:sec id="s1a">IMPORTANCE Millions die annually from respiratory disorders. Lower respiratory track gas-exchanging alveoli maintain a precarious balance between fighting invaders and minimizing tissue damage. Key players herein are resident AMs. However, there are no easily accessiblein vitromodels of HAMs, presenting a huge scientific challenge. Here we present a novel model for generating AML cells based on differentiating blood monocytes in a defined lung component cocktail. This model is non-invasive, significantly less costly than performing a bronchoalveolar lavage, yields more AML cells than HAMs per donor and retains their phenotype in culture. We have applied this model to early studies ofM. tuberculosisand SARS-CoV-2. This model will significantly advance respiratory biology research. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Arnett, Eusondia |e verfasserin |4 aut | |
| 700 | 1 | |a Simper, Jan |e verfasserin |4 aut | |
| 700 | 1 | |a Azad, Abul |e verfasserin |4 aut | |
| 700 | 1 | |a Guerrero-Arguero, Israel |e verfasserin |4 aut | |
| 700 | 1 | |a Ye, Chengjin |e verfasserin |0 (orcid)0000-0002-1934-9494 |4 aut | |
| 700 | 1 | |a Zhang, Hao |e verfasserin |4 aut | |
| 700 | 1 | |a Cai, Hong |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yufeng |e verfasserin |4 aut | |
| 700 | 1 | |a Lai, Zhao |e verfasserin |4 aut | |
| 700 | 1 | |a Jarvis, Natalie |e verfasserin |4 aut | |
| 700 | 1 | |a Lumbreras, Miranda |e verfasserin |4 aut | |
| 700 | 1 | |a Maselli-Caceres, Diego Jose |e verfasserin |4 aut | |
| 700 | 1 | |a Peters, Jay |e verfasserin |4 aut | |
| 700 | 1 | |a Torrelles, Jordi B |e verfasserin |4 aut | |
| 700 | 1 | |a Martinez-Sobrido, Luis |e verfasserin |0 (orcid)0000-0001-7084-0804 |4 aut | |
| 700 | 1 | |a Schlesinger, Larry S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2024) vom: 23. Apr. |
| 773 | 1 | 8 | |g year:2024 |g day:23 |g month:04 |
| 856 | 4 | 0 | |u https://doi.org/10.1128/mbio.00834-23 |x 0 |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2023.04.05.535806 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 23 |c 04 | ||